The preclinical use of HDAC inhibitors as therapeutic agents was effective in many animal models of neurological disorders and the study of the benefits of HDAC inhibition for treating several cognitive disorders is underway [102]. This evidence concerns the gene HDAC9 and nervous system disorder.